Asahi became aware of a negative trend for rate of the adverse events that may be associated with a manufacturing change to certain lot numbers of the products, though there is no sufficient information to date to conclusively link these adverse events to the products.
Source facts
Action
AsahiKASEI Medical Co., LTD sent a Medical DeviceRecall letter on September 21, 2012. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to confirm that they have no inventory and to forward the letter to all clinics who may have received the product requesting they check their stock and arrange for the return of any recalled product. Non-responding consignees will be contacted by telephone.
For questions regarding this recall call Asaki Kasei Medical America, Inc. at 888-362-6105.
Initiated
2012-09-21
Root cause
Process change control
Terminated
2013-02-05
Distribution
REXEED SX: Worldwide Distribution - USA including TN and the countries of Japan and Germany
REXEED LX:
Worldwide Distribution - USA including TN and Germany
Recall number
Z-2424-2012
Recall status
Terminated
CDRH record ID
112687
FDA classified
2012-09-20
Recall event number
63146
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.